skip to Main Content
CNOGA Received ANVISA Approval For Marketing In BRAZIL

Good News for Diabetics in Brazil: CNOGA Received ANVISA Approval for Marketing in BRAZIL of its Revolutionary Non-Invasive Glucometer

SAO PAULO, May 10, 2016

CNOGA Medical Ltd., today announced that they received an approval for sale in Brazil of their TensorTip™ COG™ non-invasive combo Glucometer devices from the Brazilian National Health Surveillance Agency (ANVISA – Agência Nacional de Vigilância Sanitária)). This is the first Non-invasive Glucometer to be approved by ANVISA. The CNOGA TensorTip™ COG device uses a real-time color image sensor and unique algorithms to accurately measure Glucose levels from the patient’s fingertip blood capillaries without a lancet prick, drawing blood or feeling pain, and can be measured as frequently as required with no ongoing consumable costs.

CNOGA Medical Ltd. is expecting to launch the TensorTip™ devices during Hospitilar exhibition, inSao Paulo, May 2016.

Dr. Yosef Segman, Founder and CEO of CNOGA states: “Securing ANVISA approval in Brazil is a significant milestone towards achieving our long term global expansion goals.”

Dr. Segman added: “Brazil is a rapidly growing, dynamic market for innovative non-invasive medical devices for e-health monitoring. This major milestone represents a substantial growth opportunity for CNOGA with expected commercial agreements in BRAZIL valued at tens of millions of dollars in the upcoming years. Recently, CNOGA established a diversified presence inBrazil with a CNOGA HQ in Sao Paulo” concluded Dr. Segman.

The COG is the latest addition to the portfolio of CNOGA products approved by ANVISA, thus creating the most comprehensive product-line available today in Brazil, enabling state-of-the-art E-health services to be offered to the public and significantly changing the life of diabetics, as well as other chronic patients.

About CNOGA Products

TensorTip™ Combo Glucometer (COG) is a revolutionary, painless, non-invasive approach to glucose measurement, enabling diabetics to monitor their glucose levels many times per day, everywhere, and with no prick and no blood! This device is individually calibrated for each patient and is designed for everyday use.

About CNOGA Medical Ltd.:

CNOGA Medical Ltd., a privately held international company, with offices in Israel, China, Germany & Brazil, was founded in 2004 by Dr. Yosef Segman, a technology innovator and entrepreneur. Dr. Segman has led the product development from the early stages through a strategic partnership with Texas Instruments Inc., to commercialization. The company Medical Advisor is Dr. Uriel Trahtemberg, MD/PhD Hadassah Ein-Kerem Hospital.

Press Contacts:

Mr. Ziv Gilboa

Leave a Reply

Back To Top